Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $316.99 | $47.55 | 566.68% | 1,584.95x | 93.58x | 6.47x | 8.07x | 2.58x | $941.74M | 2.73% | $4.36B | 40.00 | $32.66B | 52.95 | ||
| NVO | NOVO NORDISK A S | $37.45 | $153.23 | -75.56% | 10.26x | 1.64x | 3.42x | 5.45x | 0.11x | $9.33B | 5.58% | $30.70B | 6.88 | $183.75B | 7.61 | ||
| CORT | CORCEPT THERAPEUTICS INC | $35.70 | $41.88 | -14.75% | 37.58x | 57.69x | 4.87x | 5.86x | 0.37x | $141.79M | 3.82% | $647.81M | 6.24 | $3.68B | 81.48 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.93 | $16.88 | -47.10% | 18.60x | 15.77x | 5.92x | 3.78x | 0.24x | -$23.64M | -4.74% | $133.17M | 2.38 | $511.01M | 7.60 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $332.92 | $109.81 | 203.19% | 139.30x | 49.70x | 11.74x | 55.95x | 1.31x | $465.38M | 1.07% | $789.18M | 6.02 | $45.46B | 72.00 | ||
| SLNO | SOLENO THERAPEUTICS INC | $39.07 | $121.17 | -67.76% | 97.68x | 9.10x | 10.43x | 4.48x | 0.12x | $46.73M | 2.35% | $450.12M | 8.86 | $2.00B | 68.97 | ||
| ADMA | ADMA BIOLOGICS INC | $15.57 | $12.80 | 21.65% | 25.11x | 17.06x | 7.27x | 7.77x | 0.64x | $27.82M | 0.75% | $477.32M | 2.00 | $3.69B | 18.67 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $44.49 | $21.39 | 108.02% | 55.61x | 27.89x | 4.87x | 6.00x | 1.01x | $136.42M | 4.13% | $567.61M | 7.65 | $3.25B | 34.53 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.53 | $74.45 | -6.61% | 26.34x | 8.34x | 5.97x | 168.10x | 0.44x | $644.59M | 7.74% | $48.81M | 0.41 | $10.21B | 17.82 | ||
| VCEL | VERICEL CORP | $35.68 | $10.72 | 232.94% | 108.12x | 62.95x | 6.50x | 5.11x | 1.53x | $24.75M | 1.38% | $354.64M | 7.05 | $1.81B | 51.79 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.88 | $3.67 | -21.56% | 41.14x | 16.29x | 3.69x | 4.38x | 0.33x | -$11.69M | -5.10% | $52.91M | 0.67 | $226.14M | 25.49 | ||
| RPRX | ROYALTY PHARMA PLC | $46.21 | $48.44 | -4.60% | 25.82x | 8.91x | 8.35x | 2.74x | 0.46x | $2.22B | 11.17% | $9.71B | 22.60 | $34.99B | 32.44 | ||
| TECH | BIO-TECHNE CORP | $59.00 | $16.90 | 249.20% | 113.46x | 29.21x | 7.56x | 4.59x | 1.61x | $223.02M | 2.43% | $2.01B | 12.90 | $9.41B | 41.55 | ||
| KRYS | KRYSTAL BIOTECH INC | $275.64 | $122.42 | 125.16% | 38.93x | 33.10x | 20.50x | 6.61x | 1.29x | $189.35M | 2.37% | $1.22B | 42.14 | $7.57B | 38.62 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $198.31 | $74.26 | 167.03% | 85.85x | 23.44x | 15.45x | 4.11x | 1.23x | $30.76M | 0.79% | $950.17M | 48.53 | $4.21B | 40.91 | ||
| GMAB | GENMAB A | $29.44 | $107.00 | -72.49% | 18.99x | 1.74x | 5.08x | 3.23x | 0.11x | $1.13B | 5.98% | $5.85B | 9.10 | $22.62B | 14.65 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $20.96 | $5.48 | 282.77% | 116.44x | -18.24x | 2.63x | 7.24x | 1.79x | $45.01M | 1.70% | $370.15M | 2.93 | $2.69B | 38.37 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.12 | $19.63 | -73.92% | 3.22x | -94.99x | 731.43x | 1.62x | 0.19x | -$82.36M | -29.65% | $171.23M | 3.16 | $218.34M | 2.43 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $28.54 | $63.31 | -54.92% | 10.34x | 6.60x | 1.89x | 1.90x | 0.23x | $347.89M | 21.20% | $870.22M | 15.14 | $1.06B | 4.16 | ||
| XOMA | XOMA ROYALTY CORP | $25.53 | $16.28 | 56.81% | 31.52x | 81.20x | 6.58x | 3.60x | 0.84x | -$12.41M | -4.00% | $87.94M | 7.25 | $357.58M | 13.37 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.73 | $48.61 | 26.99% | 33.92x | 13.92x | 3.68x | 1.95x | 0.61x | $724.96M | 6.12% | $6.09B | 31.74 | $11.16B | 19.47 | ||
| MNKD | MANNKIND CORP | $3.28 | $1.48 | 121.48% | 164.00x | 37.57x | 2.87x | -19.81x | 0.91x | $13.69M | 1.37% | -$51.02M | -0.17 | $1.54B | 29.11 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.05 | $4.44 | 13.70% | 18.70x | 16.78x | 3.23x | 5.70x | 0.67x | $21.15M | 5.25% | $70.68M | 0.89 | $341.79M | 15.06 | ||
| ARGX | ARGENX SE | $766.92 | $380.32 | 101.65% | 30.92x | 25.58x | N/A | 5.46x | 1.24x | $798.86M | 1.70% | $8.62B | 140.56 | $42.96B | 27.86 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.08 | $24.20 | -4.64% | 13.19x | 12.71x | 4.79x | 2.95x | 0.63x | $208.61M | 7.39% | $954.27M | 7.80 | $2.11B | 6.56 | ||
| CRMD | CORMEDIX INC | $7.13 | $14.94 | -52.26% | 3.14x | 4.38x | 2.53x | 1.50x | 1.76x | $74.42M | 13.74% | $374.13M | 4.93 | $662.19M | 5.90 | ||
| VCYT | VERACYTE INC | $36.59 | $15.29 | 139.32% | 43.56x | 32.38x | 5.56x | 2.22x | 1.33x | $126.63M | 4.40% | $1.31B | 16.67 | $2.58B | 27.89 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $781.67 | $458.45 | 70.50% | 18.15x | 16.83x | 5.70x | 2.64x | 1.44x | $4.08B | 4.99% | $31.26B | 298.82 | $82.23B | 14.13 | ||
| EXEL | EXELIXIS INC | $44.06 | $36.82 | 19.66% | 15.30x | 13.56x | 5.16x | 5.29x | 0.84x | $875.84M | 7.32% | $2.16B | 7.96 | $11.13B | 11.19 | ||
| UTHR | UNITED THERAPEUTICS CORP | $503.90 | $254.35 | 98.12% | 16.72x | 17.10x | 7.01x | 3.11x | 2.48x | $1.04B | 4.66% | $7.10B | 160.19 | $20.53B | 11.29 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $496.83 | $193.76 | 156.41% | 32.14x | 24.37x | 10.59x | 6.76x | 1.83x | $3.19B | 2.51% | $18.67B | 73.00 | $122.97B | 25.27 | ||
| INCY | INCYTE CORP | $101.27 | $77.28 | 31.05% | 15.37x | 12.65x | 3.85x | 3.90x | 0.99x | $1.35B | 6.85% | $5.17B | 26.47 | $17.09B | 9.71 | ||
| MDXG | MIMEDX GROUP INC | $4.89 | $2.52 | 94.23% | 14.82x | 43.58x | 1.73x | 2.83x | 3.24x | $72.97M | 10.10% | $256.55M | 1.74 | $578.34M | 7.28 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.